Article Versions Notes

Nicotera AG, Di Rosa G, Turriziani L, Costanzo MC, Stracuzzi E, Vitello GA, Rando RG, Musumeci A, Vinci M, Musumeci SA, et al. Role of COMT V158M Polymorphism in the Development of Dystonia after Administration of Antipsychotic Drugs. Brain Sciences. 2021; 11(10):1293. https://doi.org/10.3390/brainsci11101293

Nicotera, Antonio Gennaro, Gabriella Di Rosa, Laura Turriziani, Maria Cristina Costanzo, Emanuela Stracuzzi, Girolamo Aurelio Vitello, Rosanna Galati Rando, Antonino Musumeci, Mirella Vinci, Sebastiano Antonino Musumeci, and et al. 2021. "Role of COMT V158M Polymorphism in the Development of Dystonia after Administration of Antipsychotic Drugs" Brain Sciences 11, no. 10: 1293. https://doi.org/10.3390/brainsci11101293

Nicotera, A. G., Di Rosa, G., Turriziani, L., Costanzo, M. C., Stracuzzi, E., Vitello, G. A., Rando, R. G., Musumeci, A., Vinci, M., Musumeci, S. A., & Calì, F. (2021). Role of COMT V158M Polymorphism in the Development of Dystonia after Administration of Antipsychotic Drugs. Brain Sciences, 11(10), 1293. https://doi.org/10.3390/brainsci11101293